The Scottish Government provided funding to support the efforts of Legion Scotland and Poppyscotland to commemorate the anniversary of VE Day through a concert at the Usher Hall on Tuesday evening. Titled Scotland’s Salute to VE Day 80, this was Scotland’s national commemorative event to mark this anniversary and told of the historic efforts which lead to victory in Europe 80 years ago.

Earlier this year, the Scottish Government wrote to MSPs and Local Authorities to highlight the funding being made available from the UK Government to arts organisations across the UK from April to August of this year to share stories of towns, cities and villages during the Second World War, as well as the funding available from the National Lottery Community Fund Awards for grants to host community events, activities and exhibitions to help tell the stories of the Second World War at a local level. I subsequently wrote to local MSPs and Local Authority Veterans Champions to reemphasise this support.

Following the publication of the UK Report in December 2024, the Scottish Government has continued to make progress in implementing the Inquiry’s recommendations through the work of the Oversight and Assurance Group, which involves patient representatives and representatives from the NHS in Scotland.

A second UK Government report provides a further update on implementation of the Inquiry’s recommendations. The report can be found at: https://www.gov.uk/government/publications/full-government-response-to-the-infected-blood-inquirys-may-2024-report).

The report includes updates on the approach being taken in Scotland, along with information on progress being made on recommendations being taken forward at UK level, such as on the provision of compensation to infected blood victims. This is in line with the Inquiry’s recommendation 12, that a detailed response to each of the Inquiry’s recommendations should be provided within one year of the publication of the Inquiry’s report of May 2024.

In Scotland, further progress has been made in a number of areas since the December report, with the overall aim of protecting patient safety and working to ensure a similar tragedy can never happen again. In particular:

• The Scottish Government and Scottish Infected Blood Support Scheme have continued to ensure additional interim compensation is paid to infected hepatitis C and HIV victims in Scotland and that estates of many of those who sadly died have been able to claim interim payments of £100,000. They have also worked closely with the UK Government and the new UK-wide Infected Blood Compensation Authority to ensure progress has been made on delivering final compensation awards.
• The Scottish Government has now agreed funding specifically for patient advocacy for 2025-26 with Haemophilia Scotland and the Scottish Infected Blood Forum.
• The Scottish Government has provided funding to the Scottish National Blood Transfusion Service to update and expand the capabilities of its existing Account for Blood system, which will allow for improved surveillance of blood usage and outcomes across Scotland.
• The Scottish Government is working with the City of Edinburgh Council and campaigners to ensure a Scottish memorial to infected blood victims is in place as soon as is feasible.

We meet regularly with the UK Government to discuss the Review of Electricity Market Arrangements (REMA) and welcome the constructive engagement we have had with them – I last met with Minister Michael Shanks MP on 23 April 2025. In addition, I have formally written to the UK Government to set out Scottish Government’s views on REMA and is planning to do so again shortly in advance of the final decision by UKG in the summer. We continue to engage with stakeholders – including consumer organisations such as Consumer Scotland – to ensure their views are represented in our discussions with the UK Government.

I refer the member to the answer to question S6W-37351 on 14 May 2025. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

Decisions on the Review of Electricity Market Arrangements (REMA) are reserved to the UK Government. The UK Government has published impact assessments and is updating its analysis ahead of a final decision this summer. We are awaiting sight of this updated modelling.

Decisions on the Review of Electricity Market Arrangements (REMA) are reserved to the UK Government. The UK Government has published impact assessments and is updating its analysis ahead of a final decision this summer. We are awaiting sight of this updated modelling.

I refer the member to the answer to question S6W-37351 on 14 May 2025. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

Decisions on the Review of Electricity Market Arrangements (REMA) are reserved to the UK Government. The UK Government has published impact assessments and is updating its analysis ahead of a final decision this summer. We are awaiting sight of this updated modelling.

Council tax is a local tax, set and administered by individual local authorities, who had full flexibility in setting rates for 2025-26. The Scottish Government’s policy towards local authorities’ spending is to allow local authorities the financial freedom to operate independently. It is for locally elected representatives to make local decisions on how best to deliver services to their local communities. There will be no reduction in the local government finance settlement as a result of extended producer responsibility for packaging payments in the first year of the scheme (2025-26).

Clozapine is available to NHS Health Boards in Scotland to prescribe as appropriate to patients with Parkinson’s Disease.

It is for Health Boards to implement treatments within services, and the decision to prescribe Clozapine would be a clinical one based on an individual patient’s symptoms and condition.